Results 31 to 40 of about 4,127 (170)
The mainstay of treatment for unresectable hepatocellular carcinoma is locoregional therapy including percutaneous ablation and transarterial chemo- and radioembolization.
Sriharsha Gummadi, MD +5 more
doaj +1 more source
Metastatic breast cancer from a hepatocellular carcinoma: a case report [PDF]
Breast metastases from extramammary malignancies are rare. Here, we report a case of breast metastasis from hepatocellular carcinoma (HCC) after breast mass excision in a 63-year-old woman.
Hyewon Bang +6 more
doaj +1 more source
Background High dose unilobar radioembolization (also termed ‘radiation lobectomy’)—the transarterial unilobar infusion of radioactive microspheres as a means of controlling tumour growth while concomitantly inducing future liver remnant hypertrophy—has ...
Daan Andel +19 more
doaj +1 more source
Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives
In the last decade trans-arterial radioembolization has given promising results in the treatment of patients with intermediate or advanced stage hepatocellular carcinoma (HCC), both in terms of disease control and tolerability profile. This technique consists of the selective intra-arterial administration of microspheres loaded with a radioactive ...
Sacco, Rodolfo +16 more
openaire +3 more sources
The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE) [PDF]
Angelina Cistaro +2 more
exaly +2 more sources
How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide [PDF]
Transarterial radioembolization consist in delivering small particles loaded with Yttrium90, a pure beta emitter, in order to treat primary and secondary liver tumors. This treatment needs precaution since inadequate delivery of these beads can lead to severe complications.
Denys A +6 more
openaire +3 more sources
Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy
Radioembolization offers a novel way to treat the nonresectable, liver predominant hepatic malignancies with better tumor response and overall progression-free survival rates.
Murthy R. Chamarthy +5 more
doaj +1 more source
Transarterial therapy: An evolving treatment modality of hepatocellular carcinoma
Liver cancer is the fifth most common cancer in men, the seventh most common in women, and the third most common cause of death from cancer worldwide.
Khalid A Jazieh +2 more
doaj +1 more source
Hepatocellular carcinoma (HCC) is one of only a few malignancies with an increasing incidence in North America. Because the vast majority of HCCs occur in the setting of a cirrhotic liver, management of this malignancy is best performed in a ...
Kelly W Burak, Norman M Kneteman
doaj +1 more source
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay +5 more
wiley +1 more source

